Your browser doesn't support javascript.
loading
Efficacy and safety of ofatumumab and bendamustine followed by ofatumumab maintenance in patients with relapsed indolent non-Hodgkin lymphoma after prior rituximab.
Lyons, Roger M; Shtivelband, Mikhail; Kingsley, Edwin; Moezi, Mehdi; Richards, Donald; Sharman, Jeff; Feng, Xiaoshu; Cannan, Megan; Fellague-Chebra, Rafik; Boyd, Thomas E.
Affiliation
  • Lyons RM; Texas Oncology, San Antonio, TX, USA.
  • Shtivelband M; US Oncology Research, The Woodlands, TX, USA.
  • Kingsley E; Ironwood Cancer and Research Center, Chandler, AZ, USA.
  • Moezi M; US Oncology Research, The Woodlands, TX, USA.
  • Richards D; Ironwood Cancer and Research Center, Chandler, AZ, USA.
  • Sharman J; Comprehensive Cancer Centers of Nevada, Las Vegas, NC, USA.
  • Feng X; US Oncology Research, The Woodlands, TX, USA.
  • Cannan M; Tyler Cancer Center, Tyler, TX, USA.
  • Fellague-Chebra R; US Oncology Research, The Woodlands, TX, USA.
  • Boyd TE; Willamette Cancer Center, Eugene, OR, USA.
Leuk Lymphoma ; 62(6): 1353-1360, 2021 06.
Article in En | MEDLINE | ID: mdl-33448893
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Estados Unidos